Author:
Steen V. D.,Medsger T. A.
Reference88 articles.
1. Steigerwald, J. C. (1979). Progressive systemic sclerosis: management. III. Immu-nosuppressive agents. Clin. Rheum. Dis., 5, 289–294.
2. Alarcon-Segovia, D. (1979). Progressive systemic sclerosis: management IV. colchicine. Clin. Rheum. Dis., 5, 294–302.
3. Jayson, M. I. V., Lovell, C., Black, C. M. et al. (1977). Penicillamine therapy in systemic sclerosis. Proc. R. Soc. Med., 70(suppl. 3), 82–88.
4. Furst, D. E., Clements, P. H., Hillis, S. et al. (1989). Immunosuppression with chlorambucil vs placebo for scleroderma. Results of a 3-year parallel, randomized, double-blind study. Arthritis Rheum., 32, 584–593.
5. Maricq, H. R., Spencer-Green, G. and LeRoy, E. C. (1976). Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis). Am. J. Med., 61, 862–870.